Here, we provide the first detailed genomic and clinicopathologic description of a rare subtype of SCLC that lacks concomitant RB1 and TP53 inactivation and arises in the absence of smoking-induced carcinogenesis. This evidence concerns the gene TP53 and small cell lung carcinoma.